Introduction
Acromegaly is characterized by excessive secretion of growth hormone, usually by an adenoma of somatotropic cells of the anterior pituitary. The level of the hormone in serum is raised and fails to suppress normally after oral or intravenous glucose (Glick et al., 1965) . In some acromegalic patients, however, circulating levels of growth hormone are partially suppressed by glucose or may even show a " paradoxical " ris; during a glucose tolerance test-for example, Glick et al. (1965) , Cryer and Daughaday (1969) , and Burger and Catt (1969) . The serum level of the hormone and the size of the pituitary adenoma vary widely in any series of acromegalic patients. Sbnksen et ad. (1967) found an association between the size of the pituitary fossa and the plasma level of growth hormone. Forrest et al. (1965) suggested that sellar size and serum level of the hormone were not correlated.
We have studied the relationship of sellar size to the serum level of growth hormone and its responsiveness to oral glucose and insulin-induced hypoglycaemia in 84 untreated acromegalic patients. The influence of age, sex, and duration of the disease was examined. In 22 untreated patients measurements of serum growth hormone were repeated within 13 months. The reproducibility of these measurements has been analysed. 
Methods
Serum growth hormone was measured by a modification of the method of radioimmunoassay described by Hartog et al. (1964) . Results were expressed as ng./ml., using the Medical Research Council reference standard " A " for human growth hormone. For every assay run during this study samples from reference pools of sera were also assayed. In 49 patients serum levels of the hormone were measured after intravenous insulin in a dose of 0 3 unit/kg. body weight (Fraser et al., 1962) . The level at one hour expressed as a percentage of the fasting level was taken as a measure of the responsiveness to insulin-induced hypoglycaemia. The serum level of the hormone was defined as unresponsive to either oral glucose or insulin-induced hypoglycaemia when the one-hour level was within +50% of the fasting level.
The size of pituitary tumour was estimated from lateral tomograms of the sella. Plain films of the pituitary fossa often fail to show large downward extensions of tumour into the sphenoid sinus, and tumour size may be grossly underrated (Fig. 1) . The tomographic cut which showed the greatest sellar expansion was selected. This radiograph was projected on to white cardboard and a tracing made of sellar outline. A straight line joining the tuberculum sellae and the tip of the dorsum formed the upper limit of the outline. Each tracing was cut out, weighed, and compared with a standard area. Corrections were made for radiographic and optical magnification. Maximum lateral gland area could be measured in 28 patients in whom pneumoencephalography was performed as described by McLachlan et al. (1969) . Seven patients showed upward extensions of the pituitary tumour, and in two the superior MEDICAL JOURNAL British Medical Journal, 1969, 4, 582-584 aspect of the tumour was sunken within the sella (Figs. 2 and  3 ). The extent of these deviations above or below the line drawn between the tuberculum and the tip of the dorsum was measured in the same way as lateral sellar area. By adding or subtracting these deviations the maximum lateral gland area was derived. This was compared with serum growth hormone levels in these 28 patients.
Results
Maximum lateral area of the sella varied nearly tenfold, from 79 to 727 sq. mm., in the 84 patients. Those who had had the disease for more than 15 years had significantly larger tumours than those who had had the disease for less than five years (Fig. 4) . Sellar area was independent of age and sex.
Mean serum growth hormone during the glucose tolerance test varied over 200-fold, from 8 to 1,860 ng./ml., in the 84 patients and was lognormally distributed. It was not correlated with age, sex, or duration of disease. In the 22 patients in whom repeat measurements of the mean serum level during a glucose tolerance test were made within 13 months the two measurements were highly correlated (Fig. 5, r=0 89 Mean serum growth hormone level was moderately well correlated with maximum lateral sellar area (r=0 47 ; P<0 001. Fig. 6 ). The correlation was slightly better in females (r= 0 55; P<0 002) than in males (r=0 39; P<0 003). In the 28 patients in whom pneumoencephalography was carried out the correlation of mean serum growth hormone with maximum lateral area at the gland was better than that with lateral area of the sella (r=0 70 compared with 0 55), but the difference was not statistically significant (0 4>P>0 3).
In the majority of patients (68/81; 84%) the serum growth hormone level was unresponsive to glucose. A minority (12/ 81 ; 15 %) showed a "paradoxical" rise in serum level at one hour, and in only one patient was the level suppressed to below 50% of the fasting level. Further analysis showed that responsiveness to glucose was related to tumour size. Lateral sellar area was less than 350 sq. mm. in 12 of the 13 patients whose growth hormone levels were responsive to glucose (Fig. 7) .
Serum growth hormone level did not respond to insulininduced hypoglycaemia in 36 of the 49 patients tested (74%). Ten patients (20%) responded normally with a greater than 50% increase in the level at one hour compared with the fasting level. In three patients the one-hour level showed a "paradoxical " suppression to less than 50% of the fasting level. 
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Patients showing a response to insulin-induced hypoglycaemia had smaller fossae than those who did not respond (Fig. 7) .
Responsiveness to hypoglycaemia and to oral glucose were related (see Table) . Of the eight patients responsive to glucose five (63%) were responsive to insulin-induced hypogly-aemia. Of Discussion Though sellar and gland volume can be predicted with reasonable accuracy from anteroposterior and lateral radiographs in the normal subject (Di Chiro and Nelson, 1962 ; McLachlan et al., 1968) , we have not attempted to measure tumour volume from radiographs. Plain x-ray films of the skull provide an inadequate picture of the size of a pituitary tumour. Lateral tomography ensures that large extensions into the sphenoid sinus are not overlooked but does not define the upper limit of a tumour. The combination of pneumoencephalography and tomography may show unexpected suprasellar extensions of a pituitary tumour. Seven out of 28 patients in whom the combined procedure was used had significant extensions above the expected position of the diaphragma sellae. Only one of these had a visual field defect. In our view the maximum lateral gland area measured by combining pneumoencephalography with tomography provides the best readily achievable estimate of tumour size.
The highly significant correlation between the maximum lateral area of the sella and the mean serum growth hormone during a glucose tolerance test in patients with untreated acromegaly suggests that growth hormone secretion is proportional to the size of the pituitary tumour. This is in agreement with the observations of Sdnksen et al. (1967) , who estimated fossa volume from anteroposterior and -lateral radiographs, tomography being used when necessary. This measurement was significantly correlated with serum growth hormone assayed during intravenous glucose tolerance tests in 16 patients with acromegaly. These authors found an inverse relationship between fossa volume and age, but this correlation was heavily weighted by two young patients with very large tumours. In our much larger series the lateral fossa area and age are not correlated. Fossa area is, however, related to duration of disease (Fig. 4) .
The responsiveness of serum growth hormone level to changes in blood sugar is probably mediated via the hypothalamus (Glick et al., 1965) . Responsiveness therefore depends on an intact pathway between hypothalamus and anterior pituitary, and on anterior pituitary cells capable of responding to stimuli from the hypothalamus. The failure of growth hormone level to respond to changes in blood glucose in patients with acromegaly can be explained in two ways. Firstly, the pathway between hypothalamus and anterior pituitary is interrupted. Secondly, the pathway is intact but there are no pituitary cells capable of responding to the stimuli. In acromegalics whose growth hormone levels remain responsive to changes in blood glucose the pathway can be presumed to be intact. Stimuli from the hypothalamus could be effected either via tumour cells or through normal anterior pituitary cells.
We have shown that size of tumour is related to responsiveness of growth hormone level to changes in blood sugar. Thus no patient with a very large tumour (maximum lateral area >350 sq. mm.) showed a response to insulin-induced hypoglycaemia and only one showed a response to oral glucose.
Thirteen of the 37 (35%) patients with smaller tumours responded normally or " paradoxically " to hypoglycaemia; 12 out of 64 (19%) showed a normal or "paradoxical" response to oral glucose. The unresponsiveness of serum growth hormone levels in patients with acromegaly reflects either pituitary stalk section or loss of somatotropic cells responsive to stimuli from the hypothalamus. The larger the tumour the more likely are these to occur.
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